Literature DB >> 11710889

Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease.

E R Martin1, W K Scott, M A Nance, R L Watts, J P Hubble, W C Koller, K Lyons, R Pahwa, M B Stern, A Colcher, B C Hiner, J Jankovic, W G Ondo, F H Allen, C G Goetz, G W Small, D Masterman, F Mastaglia, N G Laing, J M Stajich, R C Ribble, M W Booze, A Rogala, M A Hauser, F Zhang, R A Gibson, L T Middleton, A D Roses, J L Haines, B L Scott, M A Pericak-Vance, J M Vance.   

Abstract

CONTEXT: The human tau gene, which promotes assembly of neuronal microtubules, has been associated with several rare neurologic diseases that clinically include parkinsonian features. We recently observed linkage in idiopathic Parkinson disease (PD) to a region on chromosome 17q21 that contains the tau gene. These factors make tau a good candidate for investigation as a susceptibility gene for idiopathic PD, the most common form of the disease.
OBJECTIVE: To investigate whether the tau gene is involved in idiopathic PD. DESIGN, SETTING, AND PARTICIPANTS: Among a sample of 1056 individuals from 235 families selected from 13 clinical centers in the United States and Australia and from a family ascertainment core center, we tested 5 single-nucleotide polymorphisms (SNPs) within the tau gene for association with PD, using family-based tests of association. Both affected (n = 426) and unaffected (n = 579) family members were included; 51 individuals had unclear PD status. Analyses were conducted to test individual SNPs and SNP haplotypes within the tau gene. MAIN OUTCOME MEASURE: Family-based tests of association, calculated using asymptotic distributions.
RESULTS: Analysis of association between the SNPs and PD yielded significant evidence of association for 3 of the 5 SNPs tested: SNP 3, P =.03; SNP 9i, P =.04; and SNP 11, P =.04. The 2 other SNPs did not show evidence of significant association (SNP 9ii, P =.11, and SNP 9iii, P =.87). Strong evidence of association was found with haplotype analysis, with a positive association with one haplotype (P =.009) and a negative association with another haplotype (P =.007). Substantial linkage disequilibrium (P<.001) was detected between 4 of the 5 SNPs (SNPs 3, 9i, 9ii, and 11).
CONCLUSIONS: This integrated approach of genetic linkage and positional association analyses implicates tau as a susceptibility gene for idiopathic PD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710889      PMCID: PMC3973175          DOI: 10.1001/jama.286.18.2245

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  25 in total

1.  Tau is a candidate gene for chromosome 17 frontotemporal dementia.

Authors:  P Poorkaj; T D Bird; E Wijsman; E Nemens; R M Garruto; L Anderson; A Andreadis; W C Wiederholt; M Raskind; G D Schellenberg
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

2.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

3.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

4.  Avoiding recomputation in linkage analysis.

Authors:  A A Schäffer; S K Gupta; K Shriram; R W Cottingham
Journal:  Hum Hered       Date:  1994 Jul-Aug       Impact factor: 0.444

5.  Genetic evidence for the involvement of tau in progressive supranuclear palsy.

Authors:  C Conrad; A Andreadis; J Q Trojanowski; D W Dickson; D Kang; X Chen; W Wiederholt; L Hansen; E Masliah; L J Thal; R Katzman; Y Xia; T Saitoh
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

6.  What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study.

Authors:  A J Hughes; Y Ben-Shlomo; S E Daniel; A J Lees
Journal:  Neurology       Date:  1992-06       Impact factor: 9.910

7.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.

Authors:  E H Corder; A M Saunders; N J Risch; W J Strittmatter; D E Schmechel; P C Gaskell; J B Rimmler; P A Locke; P M Conneally; K E Schmader
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

8.  Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.

Authors:  M Hutton; C L Lendon; P Rizzu; M Baker; S Froelich; H Houlden; S Pickering-Brown; S Chakraverty; A Isaacs; A Grover; J Hackett; J Adamson; S Lincoln; D Dickson; P Davies; R C Petersen; M Stevens; E de Graaff; E Wauters; J van Baren; M Hillebrand; M Joosse; J M Kwon; P Nowotny; L K Che; J Norton; J C Morris; L A Reed; J Trojanowski; H Basun; L Lannfelt; M Neystat; S Fahn; F Dark; T Tannenberg; P R Dodd; N Hayward; J B Kwok; P R Schofield; A Andreadis; J Snowden; D Craufurd; D Neary; F Owen; B A Oostra; J Hardy; A Goate; J van Swieten; D Mann; T Lynch; P Heutink
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

9.  Fluorescence-based oligonucleotide ligation assay for analysis of cystic fibrosis transmembrane conductance regulator gene mutations.

Authors:  F A Eggerding; D M Iovannisci; E Brinson; P Grossman; E S Winn-Deen
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

Review 10.  Epidemiology of Parkinson's disease.

Authors:  C M Tanner; S M Goldman
Journal:  Neurol Clin       Date:  1996-05       Impact factor: 3.806

View more
  47 in total

1.  Direct micro-haplotyping by multiple double PCR amplifications of specific alleles (MD-PASA).

Authors:  Yuval Eitan; Yechezkel Kashi
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

Review 2.  Rare genetic mutations shed light on the pathogenesis of Parkinson disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 3.  The genetic basis of Parkinson's disease.

Authors:  T Foltynie; S Sawcer; C Brayne; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

4.  Single nucleotide polymorphism seeking long term association with complex disease.

Authors:  Brian W Kirk; Matthew Feinsod; Reyna Favis; Richard M Kliman; Francis Barany
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

5.  Accounting for linkage in family-based tests of association with missing parental genotypes.

Authors:  Eden R Martin; Meredyth P Bass; Elizabeth R Hauser; Norman L Kaplan
Journal:  Am J Hum Genet       Date:  2003-10-09       Impact factor: 11.025

6.  Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models.

Authors:  Preeti J Khandelwal; Sonya B Dumanis; Alexander M Herman; G William Rebeck; Charbel E-H Moussa
Journal:  Mol Cell Neurosci       Date:  2011-09-14       Impact factor: 4.314

Review 7.  The genetics of Parkinson's disease.

Authors:  Kah Leong Lim; Valina L Dawson; Ted M Dawson
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

8.  Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease.

Authors:  Mia E-L Blomqvist; Peter A Silburn; Daniel D Buchanan; Niels Andreasen; Kaj Blennow; Nancy L Pedersen; Anthony J Brookes; George D Mellick; Jonathan A Prince
Journal:  Neurogenetics       Date:  2004-04-16       Impact factor: 2.660

9.  Parkin attenuates wild-type tau modification in the presence of beta-amyloid and alpha-synuclein.

Authors:  Charbel E-H Moussa
Journal:  J Mol Neurosci       Date:  2008-06-17       Impact factor: 3.444

10.  H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers.

Authors:  Elisa Canu; Marina Boccardi; Roberta Ghidoni; Luisa Benussi; Cristina Testa; Michela Pievani; Matteo Bonetti; Giuliano Binetti; Giovanni B Frisoni
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.